These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 11433896)
1. Are there predictive factors of severe liver fibrosis in morbidly obese patients with non-alcoholic steatohepatitis? Crespo J; Fernández-Gil P; Hernández-Guerra M; Cayón A; Mayorga M; Domínguez-Diez A; Fernández-Escalante JC; Pons-Romero F Obes Surg; 2001 Jun; 11(3):254-7. PubMed ID: 11433896 [TBL] [Abstract][Full Text] [Related]
2. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease. Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634 [TBL] [Abstract][Full Text] [Related]
3. Non-alcoholic steatohepatitis in children. Nanda K Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336 [TBL] [Abstract][Full Text] [Related]
6. Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery. Beymer C; Kowdley KV; Larson A; Edmonson P; Dellinger EP; Flum DR Arch Surg; 2003 Nov; 138(11):1240-4. PubMed ID: 14609874 [TBL] [Abstract][Full Text] [Related]
7. Hepatic histology in obese patients undergoing bariatric surgery. Machado M; Marques-Vidal P; Cortez-Pinto H J Hepatol; 2006 Oct; 45(4):600-6. PubMed ID: 16899321 [TBL] [Abstract][Full Text] [Related]
8. Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease. Weiner RA Dig Dis; 2010; 28(1):274-9. PubMed ID: 20460923 [TBL] [Abstract][Full Text] [Related]
9. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients. Ong JP; Elariny H; Collantes R; Younoszai A; Chandhoke V; Reines HD; Goodman Z; Younossi ZM Obes Surg; 2005 Mar; 15(3):310-5. PubMed ID: 15826462 [TBL] [Abstract][Full Text] [Related]
10. [Relationship between morphological diagnosis of NASH (non-alcoholic steatohepatitis) and liver function tests in a group of patients with morbid obesity]. Chavarría-Arciniega S; López-Alvarenga JC; Uribe-Uribe NO; Herrera-Hernández M; González-Barranco J Rev Invest Clin; 2005; 57(4):505-12. PubMed ID: 16315634 [TBL] [Abstract][Full Text] [Related]
11. Effects of bariatric surgery on nonalcoholic fatty liver disease: preliminary findings after 2 years. Furuya CK; de Oliveira CP; de Mello ES; Faintuch J; Raskovski A; Matsuda M; Vezozzo DC; Halpern A; Garrido AB; Alves VA; Carrilho FJ J Gastroenterol Hepatol; 2007 Apr; 22(4):510-4. PubMed ID: 17376042 [TBL] [Abstract][Full Text] [Related]
12. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Angulo P; Keach JC; Batts KP; Lindor KD Hepatology; 1999 Dec; 30(6):1356-62. PubMed ID: 10573511 [TBL] [Abstract][Full Text] [Related]
14. Predictors of nonalcoholic steatohepatitis in patients undergoing bariatric surgery: when is liver biopsy indicated? Helling TS; Helzberg JH; Nachnani JS; Gurram K Surg Obes Relat Dis; 2008; 4(5):612-7. PubMed ID: 18226970 [TBL] [Abstract][Full Text] [Related]
15. The importance of routine liver biopsy in diagnosing nonalcoholic steatohepatitis in bariatric patients. Shalhub S; Parsee A; Gallagher SF; Haines KL; Willkomm C; Brantley SG; Pinkas H; Saff-Koche L; Murr MM Obes Surg; 2004 Jan; 14(1):54-9. PubMed ID: 14980034 [TBL] [Abstract][Full Text] [Related]
16. Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease. Mathurin P; Hollebecque A; Arnalsteen L; Buob D; Leteurtre E; Caiazzo R; Pigeyre M; Verkindt H; Dharancy S; Louvet A; Romon M; Pattou F Gastroenterology; 2009 Aug; 137(2):532-40. PubMed ID: 19409898 [TBL] [Abstract][Full Text] [Related]
17. Serum proteomic profiling of obese patients: correlation with liver pathology and evolution after bariatric surgery. Trak-Smayra V; Dargere D; Noun R; Albuquerque M; Yaghi C; Gannagé-Yared MH; Bedossa P; Paradis V Gut; 2009 Jun; 58(6):825-32. PubMed ID: 18403495 [TBL] [Abstract][Full Text] [Related]
18. Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease. Abrams GA; Kunde SS; Lazenby AJ; Clements RH Hepatology; 2004 Aug; 40(2):475-83. PubMed ID: 15368453 [TBL] [Abstract][Full Text] [Related]
19. Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement. Dixon JB; Bhathal PS; O'Brien PE Obes Surg; 2006 Oct; 16(10):1278-86. PubMed ID: 17059735 [TBL] [Abstract][Full Text] [Related]
20. Histopathologic variability between the right and left lobes of the liver in morbidly obese patients undergoing Roux-en-Y bypass. Larson SP; Bowers SP; Palekar NA; Ward JA; Pulcini JP; Harrison SA Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1329-32. PubMed ID: 17702661 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]